Search
Sorbitan monostearate
go.drugbank.com/drugs/DB20996ExperimentalSorbitan monostearate has a monoisotopic molecular weight of 430.33 Da.
Furacrinic acid
go.drugbank.com/drugs/DB21223ExperimentalFuracrinic acid has a monoisotopic molecular weight of 258.09 Da.
Xantofyl palmitate
go.drugbank.com/drugs/DB21273ExperimentalXantofyl palmitate has a monoisotopic molecular weight of 1044.89 Da.
Cromoglicate lisetil
go.drugbank.com/drugs/DB21297ExperimentalCromoglicate lisetil has a monoisotopic molecular weight of 652.23 Da.
Iobutoic acid
go.drugbank.com/drugs/DB21443ExperimentalIobutoic acid has a monoisotopic molecular weight of 670.82 Da.
RPI-78M
go.drugbank.com/drugs/DB05740ExperimentalRPI-78M is being developed for the treatment of multiple sclerosis (MS). Other neurological disorders that may be served by RPI-78M include myasthenia gravis (MG), muscular dystrophy (MD) and amyotrophic lateral sclerosis (ALS).
3,4-Methylenedioxy-N-isopropylamphetamine
go.drugbank.com/drugs/DB06112ExperimentalMDI-P has demonstrated potent anti-HIV activity. MDI-P has been shown to be effective in killing HIV in cell culture. HIV is the virus that causes acquired immune deficiency syndrome (AIDS).
4'-Methylene-5,8,10-trideazaaminopterin
go.drugbank.com/drugs/DB05616InvestigationalIt has been investigated for the treatment of Rheumatoid Arthritis (phase II). … CH-1504 is a an antirheumatic agent that has been shown in vitro to be a nonpolyglutamylatable and nonhydroxylatable antifolate that is more efficiently taken up into cells by the reduced folate carrier
Barzuxetan
go.drugbank.com/drugs/DB21132ExperimentalBarzuxetan has a monoisotopic molecular weight of 594.2 Da.